3-Hydroxyphencyclidine (3-HPC), a derivative of phencyclidine (PCP), is increasingly attracting clinical scrutiny due to limited evidence suggesting distinct pharmacological properties. Preliminary analyses indicate https://www.pinterest.com/pin/1140888518124046392/